Bosnalijek d.d.
🇧🇦Bosnia and Herzegovina
- Country
- 🇧🇦Bosnia and Herzegovina
- Ownership
- Private
- Established
- 1951-01-10
- Employees
- 501
- Market Cap
- -
- Website
- http://bosnalijek.com
Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Phase 2
1 (33.3%)Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection
Phase 2
Completed
- Conditions
- COVID-19 Infection
- Interventions
- Drug: The standard of care
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2020-12-24
- Lead Sponsor
- Bosnalijek D.D
- Target Recruit Count
- 120
- Registration Number
- NCT04374032
- Locations
- 🇧🇦
Clinical Center University of Sarajevo, Sarajevo, Sarajevo Canton, Bosnia and Herzegovina
🇧🇦University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina
🇧🇦University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS
Phase 3
Terminated
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- Drug: INF beta-1a
- First Posted Date
- 2017-09-14
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Bosnalijek D.D
- Target Recruit Count
- 301
- Registration Number
- NCT03283397
- Locations
- 🇹🇷
Kocaeli University, Faculty of Medicine, Department of Neurology, Kocaeli, Turkey
Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat
Phase 3
Completed
- Conditions
- Sore Throat
- Interventions
- Drug: Pharyngal® Oromucosal SprayDrug: Lysobact Complete SpreyDrug: Placebo
- First Posted Date
- 2017-09-13
- Last Posted Date
- 2021-03-16
- Lead Sponsor
- Bosnalijek D.D
- Target Recruit Count
- 346
- Registration Number
- NCT03282045
- Locations
- 🇧🇦
University Clinical Center of the Republic of Srpska, ENT Clinic, Banja Luka, Bosnia and Herzegovina, Banja Luka, Bosnia and Herzegovina
News
No news found